Titlebook: Chimera Research; Methods and Protocol Insoo Hyun,Alejandro De Los Angeles Book 2019 Springer Science+Business Media, LLC, part of Springer

nourish

書目名稱Chimera Research影響因子(影響力)




書目名稱Chimera Research影響因子(影響力)學科排名




書目名稱Chimera Research網(wǎng)絡(luò)公開度




書目名稱Chimera Research網(wǎng)絡(luò)公開度學科排名




書目名稱Chimera Research被引頻次




書目名稱Chimera Research被引頻次學科排名




書目名稱Chimera Research年度引用




書目名稱Chimera Research年度引用學科排名




書目名稱Chimera Research讀者反饋




書目名稱Chimera Research讀者反饋學科排名

雜役

Prologue

Negligible

Introduction to Health Physics,We provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two

anesthesia

GILD

,Radioactive Atoms–Nature and Behavior,generate interspecies chimeras between humans and animals. While some jurisdictions prohibit the introduction of human PS cells into monkey preimplantation embryos, other jurisdictions may permit and even encourage such experiments. Therefore, it is useful to consider blastocyst complementation expe

GILD

Book 2019the ethics of crossing the xenobarrier; animal welfare; experimentation with spermatogonial stem cells; and cautious approaches to human-monkey chimera studies to further understand complex human brain disorders. Written in the highly successful .Methods in Molecular Biology. series format, chapters

GLOSS

Frontiers of Pluripotencyhas been defined by competence to form germline chimeras and governance by unique KLF-based transcription factor (TF) circuitry, whereas primed state is distinguished by an inability to generate chimeras and alternative TF regulation. However, the discovery of many alternative PS cell states challen

AUGER

Intentional

Embryonic Chimeras with Human Pluripotent Stem CellsWe provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two